EML4-ALK AND ITS INHIBITORS: A NEW PARADIGM IN CANCER TREATMENT

被引：0
|
作者：
Mano, H. [1 ,2 ]
机构：
[1] Jichi Med Univ, Div Funct Genom, Shimotsuke, Japan
[2] Univ Tokyo, Grad Sch Med, Dept Med Genom, Tokyo 1138654, Japan
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：79 / 79
页数：1
相关论文
共 50 条
  • [31] A Novel EML4-ALK Variant Exon 6 of EML4 Fused to Exon 19 of ALK
    Penzel, Roland
    Schirmacher, Peter
    Warth, Arne
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (07) : 1198 - 1199
  • [32] Dividing and conquering the variation among variants in EML4-ALK lung cancer
    Bivona, Trever G.
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S369 - S370
  • [33] ALK F1174S mutation impairs ALK kinase activity in EML4-ALK variant 1 and sensitizes EML4-ALK variant 3 to crizotinib
    Guan, Jikui
    Chuang, Tzu-Po
    Vikstrom, Anders
    Palmer, Ruth H.
    Hallberg, Bengt
    FRONTIERS IN ONCOLOGY, 2024, 13
  • [34] Discovery and Development of Lorlatinib: A Macrocyclic Inhibitor of EML4-ALK for the Treatment of NSCLC
    Dugger R.
    Li B.
    Richardson P.
    ACS Symposium Series, 2019, 1332 : 27 - 59
  • [35] Clinico-pathologic features of lung cancer with EML4-ALK translocation
    Mitsudomi, T.
    Suda, K.
    Tomizawa, K.
    Yatabe, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [36] Identification of an EML4-ALK rearrangement in an intrahepatic cholangiocarcinoma
    Favre, Loetitia
    Pujals, Anais
    Maille, Pascale
    Poullot, Elsa
    Calderaro, Julien
    PATHOLOGY INTERNATIONAL, 2021, 71 (09) : 630 - 632
  • [37] The EML4-ALK oncogene: targeting an essential growth driver in human cancer
    Mano, Hiroyuki
    PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES, 2015, 91 (05): : 193 - 201
  • [38] Amphiregulin confers in vivo crizotinib-resistance of EML4-ALK lung cancer and circumvention by EGFR inhibitors
    Taniguchi, Hirokazu
    Takeuchi, Shinji
    Fukuda, Koji
    Nakagawa, Takayuki
    Arai, Sachiko
    Nanjo, Shigeki
    Yamada, Tadaaki
    Yamaguchi, Hiroyuki
    Mukae, Hiroshi
    Yano, Seiji
    CANCER SCIENCE, 2018, 109 : 736 - 736
  • [39] EML4-ALK Fusions: Propelling Cancer but Creating Exploitable Chaperone Dependence
    Workman, Paul
    van Montfort, Rob
    CANCER DISCOVERY, 2014, 4 (06) : 642 - 645
  • [40] Discovery and clinical application of a novel oncogene, EML4-ALK, in lung cancer
    Mano, Hiroyuki
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (06) : S214 - S214
12345